Peeps, Mike and Ike launch summer flavors
BETHLEHEM, Pa. — Peeps candy, a Just Born brand, will roll out two new summertime flavors to retailers nationwide, the company announced today. Just Born also announced Mike and Ike Lemonade Blends will return for its fourth consecutive summer.
The new Peeps products include Peeps Bubble Gum-flavored Marshmallow Chicks and Peeps Sweet Lemonade Marshmallow Chicks.
Peeps Sweet Lemonade Chicks are available in a two-count package with a suggested retail price of $0.99 to $1.29.
Peeps Bubble Gum Chicks are available in a 10-count package with an SRP of $1.49.
Mike and Ike Lemonade Blends are available in a 5-oz. theatre box and have an SRP of $0.99 to $1.29.
Mark Hoffman, senior brand manager for Peeps at Just Born, said, "Peeps have established themselves for a range of holidays beyond Easter, but entering the summer season with two special Peeps products is very exciting! Our lemonade and bubble gum products are delicious and will amaze young and mature Peeps fans alike. We are also pleased to have our Peeps join Mike and Ike in the cause to raise awareness and funds for Alex’s Lemonade Stand Foundation and the fight against childhood cancer."
Alex’s Lemonade Stand Foundation is a nonprofit dedicated to finding cures for all kids with cancer, and a portion of the proceeds from the three Just Born candies will benefit the foundation.
Peeps and Mike and Ike candies are available at Target, Rite Aid, Walgreens and other retailers across the country.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
FDA approves Alcon’s Simbrinza
BASEL, Switzerland — The Food and Drug Administration has approved a drug made by Alcon, the drug maker said.
Alcon, a subsidiary of Swiss drug maker Novartis, announced the approval of Simbrinza (brinzolamide and brimonidine tartrate) for elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Elevated IOP is the only modifiable risk factor for glaucoma, the company said. Glaucoma affects more than 2.2 million Americans and is the second-leading cause of preventable blindness worldwide, according to the Glaucoma Research Foundation and Lighthouse International.
"Alcon is the global leader in providing both pharmaceutical and surgical options for patients living with glaucoma," Alcon U.S. and Canada area president Robert Warner said. "The introduction of Simbrinza further expands our ability to provide effective treatments for patients with elevated IOP."
Investigation into Schnucks card-hacking incident nears end
ST. LOUIS — More than 2 million credit and debit cards at nearly all of Schnuck Markets’ stores may have been compromised as part of a recent hacking incident, the company said.
The company nevertheless emphasized that cardholders’ names, addresses and other identifying information was not accessed, only the card numbers and expiration dates. About 2.4 million cards are believed to have been compromised at 79 of the chain’s 100 stores, and the company has set up a Web page with information on the attack and a video by chairman and CEO Scott Schnuck.
"On behalf of myself, the Schnuck family and all of our 15,000 teammates, I apologize to everyone affected by this incident," Schnuck said. "Over the years, technology has helped us deliver customer service, but it also introduces risks that we have actively worked to manage through compliance audits, encryption technology and various other security measures."
The company said last month that it was the victim of an attack on its computer network in which a computer code was designed to capture magnetic stripe data from customers’ credit and debit cards.